Stratos Wealth Partners, Ltd. Akebia Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$5.39 - $9.15 $485 - $823	-90 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$7.44 - $10.65 $669 - $958	90 New	90 $1,000
Q2 2018 Aug 13, 2018	SELL	$9.15 - $11.34 $823 - $1,020	-90 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$9.53 - $15.68 $6,194 - $10,192	-650 Reduced 87.84%	90 $1,000
Q4 2017 Feb 09, 2018	BUY	$14.24 - $19.59 $10,537 - $14,496	740	740 $11,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.